Previous Close | 19.25 |
1-Year Change | -25.9% |
6-Months Change | -29.1% |
3-Months Change | 4.85% |
Moving Avg (50d) | 19.244 |
Moving Avg (200d) | 23.233 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.86B |
Beta (3-Years) | 1.44 |
Revenue Growth (ttm) | -14.61% |
Net Profit Margin (ttm) | -5.13% |
Return On Assets (ttm) | -3.88% |
EPS (ttm) | -2.08 |
PE Ratio (ttm) | -9.25 |
Dividend Yield | 5.19% |
Asset Description: | The Chemours Company |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-04 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
18.865 | 18.288 | 17.903 | 17.325 | 16.363 | 15.4 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.